Advertisement
Screener

EVOFEM BIOSCIENCES, INC. (EVFM) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

1.9 / 5 stars · 29/78 Roast Me

EVOFEM BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate

EVOFEM BIOSCIENCES, INC. (EVFM) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-27.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2023-04-27

  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.00%.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2018-09-30 was 0.00%.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2018-06-30 was 0.00%.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2017-06-30 was 0.00%.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2021 was 0.00%.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2020 was 0.00%.
  • EVOFEM BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2019 was 0.00%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month
2022-12-310.00%
10-K · filed 2023-04-27
2021-12-310.00%
10-K · filed 2023-04-27
2020-12-310.00%
10-K · filed 2022-03-10
2019-12-310.00%
10-K · filed 2021-03-04
2019-03-310.00%
10-Q · filed 2019-05-07
2018-12-310.00%
10-K · filed 2020-03-12
2018-09-300.00%
10-Q · filed 2018-11-07
0.00%
10-Q · filed 2018-11-07
2018-06-300.00%
10-Q · filed 2018-08-02
0.00%
10-Q · filed 2018-08-02
2017-12-310.00%
10-K · filed 2019-03-01
2017-09-300.00%
10-Q · filed 2018-11-07
2017-06-300.00%
10-Q · filed 2018-08-02
0.00%
10-Q · filed 2018-08-02
2017-03-310.00%
10-Q · filed 2018-05-14
2016-12-310.00%
8-K/A · filed 2018-04-06
2015-12-310.00%
10-K · filed 2018-02-26
2014-12-310.00%
10-K · filed 2017-03-23